rs12898729

This variant is located in the HERC2 gene.

GWAS Catalog Trait Associations (5)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

rosacea

Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele G
OR 0.12
p 3.0e-14
N 442,187
Major Consortium StudyLarge GWAS
European

benign neoplasm of eye

Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele G
OR 0.38
p 2.0e-12
N 59,198
Major Consortium StudyLarge GWAS
Hispanic or Latin American

skin disease

Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele G
OR 0.08
p 6.0e-12
N 421,291
Major Consortium StudyLarge GWAS
European

body height

Allele A
OR 0.01
p 3.0e-8
N 928,679
Large GWAS
multi-ancestry

eye colour measurement

Jonnalagadda M et al. A Genome-Wide Association Study of Skin and Iris Pigmentation among Individuals of South Asian Ancestry. Genome Biology and Evolution 11(4):1066-1076 (2019)
Allele A
OR 0.79
p 4.0e-11
N 329
Small GWAS
South Asian

About HERC2

This gene belongs to the HERC gene family that encodes a group of unusually large proteins, which contain multiple structural domains. All members have at least 1 copy of an N-terminal region showing homology to the cell cycle regulator RCC1 and a C-terminal HECT (homologous to E6-AP C terminus) domain found in a number of E3 ubiquitin protein ligases. Genetic variations in this gene are associated with skin/hair/eye pigmentation variability. Multiple pseudogenes of this gene are located on chromosomes 15 and 16. [provided by RefSeq, Mar 2012]

View all HERC2 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…